Page last updated: 2024-08-21

silicon carbide and Hyperplasia

silicon carbide has been researched along with Hyperplasia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deleanu, D; Dorobantu, M; Hamon, M; Niculescu, R; Waksman, R; Weissman, NJ	1
Abizaid, A; Albertal, M; Feres, F; Mattos, LA; Paula, JE; Pinto, IM; Sousa, AG; Sousa, JE; Staico, R; Tanajura, LF	1
Akiyama, I; Morimoto, Y; Ogami, A; Oyabu, T; Tanaka, I; Yamato, H	1

Trials

1 trial(s) available for silicon carbide and Hyperplasia

Article	Year
[Randomized intravascular ultrasound comparison between endoprostheses with and without amorphous silicon-carbide]. Arquivos brasileiros de cardiologia, 2004, Volume: 83 Spec No Topics: Biocompatible Materials; Carbon Compounds, Inorganic; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Humans; Hyperplasia; Male; Middle Aged; Prospective Studies; Silicon Compounds; Stents; Treatment Outcome; Tunica Intima; Ultrasonography	2004

Article

Year

[Randomized intravascular ultrasound comparison between endoprostheses with and without amorphous silicon-carbide].

Arquivos brasileiros de cardiologia, 2004, Volume: 83 Spec No

Topics: Biocompatible Materials; Carbon Compounds, Inorganic; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Humans; Hyperplasia; Male; Middle Aged; Prospective Studies; Silicon Compounds; Stents; Treatment Outcome; Tunica Intima; Ultrasonography

2004

Other Studies

2 other study(ies) available for silicon carbide and Hyperplasia

Article	Year
Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2013, Jan-22, Volume: 8, Issue:9 Topics: Aged; Carbon Compounds, Inorganic; Chromium Alloys; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Hyperplasia; Incidence; Male; Middle Aged; Myocardial Infarction; Neointima; Percutaneous Coronary Intervention; Prospective Studies; Silicon Compounds; Sirolimus; Treatment Outcome	2013
Pulmonary effects and biopersistence of deposited silicon carbide whisker after 1-year inhalation in rats. Inhalation toxicology, 2007, Volume: 19, Issue:2 Topics: Administration, Inhalation; Animals; Body Weight; Bronchi; Carbon Compounds, Inorganic; Hyperplasia; Longevity; Lung; Male; Mineral Fibers; Organ Size; Particle Size; Pulmonary Alveoli; Rats; Rats, Wistar; Silicon Compounds; X-Ray Diffraction	2007

Article

Year

Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2013, Jan-22, Volume: 8, Issue:9

Topics: Aged; Carbon Compounds, Inorganic; Chromium Alloys; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Hyperplasia; Incidence; Male; Middle Aged; Myocardial Infarction; Neointima; Percutaneous Coronary Intervention; Prospective Studies; Silicon Compounds; Sirolimus; Treatment Outcome

2013

Pulmonary effects and biopersistence of deposited silicon carbide whisker after 1-year inhalation in rats.

Inhalation toxicology, 2007, Volume: 19, Issue:2

Topics: Administration, Inhalation; Animals; Body Weight; Bronchi; Carbon Compounds, Inorganic; Hyperplasia; Longevity; Lung; Male; Mineral Fibers; Organ Size; Particle Size; Pulmonary Alveoli; Rats; Rats, Wistar; Silicon Compounds; X-Ray Diffraction

2007